Stock Events

Stock Events

Search...

Ligand Pharmaceuticals (LGND) Q3 2025 Earnings

7AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

1.19

1.41

1.62

1.84

Details

Expected EPS

1.421429

Actual EPS

1.6

Surprise EPS

0.18

Surprise Percent

+12.56%

Description

Ligand Pharmaceuticals (LGND) has reported earnings of 1.6 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.